Quick Answer
Elevance Health, Inc. reported Net Income Loss of $5.66 billion for the year ending 2025.
- Elevance Health, Inc. showed a decrease of -5.3% in Net Income Loss from 2024 to 2025.
- This data is from Elevance Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), Elevance Health, Inc.'s Net Income Loss has grown by 127.3%.
- Historical annual values: Fiscal year 2025: $5.66 billion | Fiscal year 2024: $5.98 billion | Fiscal year 2023: $5.99 billion | Fiscal year 2022: $5.89 billion | Fiscal year 2021: $6.16 billion | Fiscal year 2020: $4.57 billion | Fiscal year 2019: $4.81 billion | Fiscal year 2018: $3.75 billion | Fiscal year 2017: $3.84 billion | Fiscal year 2016: $2.47 billion | Fiscal year 2015: $2.56 billion | Fiscal year 2014: $2.57 billion | Fiscal year 2013: $2.49 billion | Fiscal year 2012: $2.66 billion | Fiscal year 2011: $2.65 billion | Fiscal year 2010: $2.89 billion | Fiscal year 2009: $4.75 billion | Fiscal year 2008: $2.49 billion.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: